Breaking Finance News

Panmure Gordon disclosed Allergy Therapeutics PLC (LON:AGY), retaining its price target at 53.00GBX earlier today

Having a price of 20.75GBX, Allergy Therapeutics PLC (LON:AGY) traded 3.65% higher on the day. With the last close down -7.00% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. AGY has recorded a 50-day average of 18.82GBX and a two hundred day average of 22.15GBX. Trade Volume was down over the average, with 223,096 shares of AGY changing hands under the typical 415,903

Reporting a potential upside of 1.55%, Panmure Gordon hold steady the price target of Allergy Therapeutics PLC (LON:AGY) at 53.00GBX

On 09/26/2016, Numis released a statement on Allergy Therapeutics PLC (LON:AGY) maintained the target price at 37.00GBX that suggested an upside of 1.10%.

Recent Performance Chart

Allergy Therapeutics PLC (LON:AGY)

Allergy Therapeutics PLC has with a one year low of 17.25GBX and a one year high of 34.82GBX and has a market capitalization of 0 GBX.

A total of 3 analysts have released a report on Allergy Therapeutics PLC. One analyst rating the company a strong buy, one analyst rating the company a buy, zero analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of 64.67GBX.

General Company Details For Allergy Therapeutics PLC (LON:AGY)

Allergy Therapeutics Plc is a United Kingdom-based pharmaceutical company. The Company focuses on the treatment and prevention of allergy with aluminum free products. It provides information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with focus on allergy vaccination, which is also known as specific immunotherapy or desensitization therapy. The Company's business segments are Central Europe, which includes segments, such as Germany, Austria, Switzerland and the Netherlands; Southern Europe, which includes segments, such as Italy and Spain; the United Kingdom, which includes Latin America, and Rest of World. It offers products, such as Pollinex Trees, Pollinex Grasses + Rye and Skin Prick Testing; Diagnostic Products, such as Pollen, Foods, Moulds, Arthropods and Epithelia, and the United Kingdom Special products, including Pollinex Quattro, Tyrosine TU t.o.p, Oralvac Compact, and DAP Penicillin/DAP Amoxicillin/DAP Clavulanic.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.